openPR Logo
Press release

United States Pigmented Lesion Treatment Market expected to grow at a high CAGR during 2024-2031 | Top Companies - Alma Lasers Ltd, Cutera Inc., Cynosure Inc.

11-06-2025 01:22 PM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Pigmented Lesion Treatment Market

Pigmented Lesion Treatment Market

"Pigmented Lesion Treatment Market is expected to reach at a high CAGR during the forecast period 2024-2031." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/pigmented-lesion-treatment-market?sp

United States: Recent Industry Developments

✅ In November 2025, Cynosure, Inc. launched a next-generation Q-switched Nd:YAG laser system for treating pigmented lesions, offering faster pulse rates and improved precision for epidermal and dermal pigmentation removal. The system enhances patient comfort and minimizes downtime. It reinforces Cynosure's leadership in aesthetic and dermatologic laser solutions in the U.S.

✅ In October 2025, Candela Medical introduced the GentleLase Pro with dual-wavelength capability to treat melasma, lentigines, and other pigmented lesions more effectively, integrating AI-assisted skin mapping for optimized treatment parameters. The device improves outcomes across diverse skin types. It highlights the U.S. trend toward smarter, multi-functional dermatologic lasers.

✅ In September 2025, Lumenis Inc. launched an advanced picosecond laser platform specifically designed for refractory pigmented lesions and tattoo removal, providing high peak power with minimal thermal damage to surrounding tissue. The system enhances clinical efficacy and patient satisfaction. It demonstrates U.S. innovation in precision aesthetic dermatology.

✅ In August 2025, Cutera, Inc. expanded its portfolio with a non-ablative fractional laser optimized for combined pigment and texture correction, supporting safe, repeatable treatments in dermatology clinics. The platform reduces recovery time and post-treatment complications. It underscores U.S. investment in versatile, patient-friendly laser solutions.

Japan: Recent Industry Developments

✅ In November 2025, Alma Japan launched a high-precision Q-switched laser for pigmented lesion therapy, offering shorter pulse durations and enhanced cooling to minimize side effects in Japanese patients. The system targets melasma, solar lentigines, and nevi. It reflects Japan's focus on safer, effective dermatologic laser treatments.

✅ In October 2025, Canon Medical Systems Japan introduced a fractional laser platform for combined pigment and scar management, integrating real-time skin feedback for precision treatment and reduced downtime. The system improves efficacy across various skin types. It demonstrates Japan's commitment to advanced, technology-driven dermatology solutions.

✅ In September 2025, Hoya Corporation (Medical Division) launched a picosecond laser for pigmented lesion removal in clinics, optimized for both cosmetic and therapeutic indications, enhancing safety and patient satisfaction. The device supports precise targeting with minimal surrounding tissue damage. It highlights Japan's investment in next-generation dermatologic laser systems.

✅ In August 2025, Nidek Co., Ltd. expanded its laser dermatology portfolio with a dual-wavelength system for treating refractory pigmented lesions, enabling adjustable parameters for diverse skin phototypes. The platform enhances clinical outcomes and treatment flexibility. It underscores Japan's focus on innovative, patient-centered aesthetic solutions.

Pigmented Lesion Treatment Market: Drivers

The pigmented lesion treatment market is experiencing significant growth due to rising awareness of skin health and cosmetic concerns among consumers. Increasing prevalence of hyperpigmentation, age spots, and melasma is driving demand for both medical and aesthetic treatment options. Advanced technologies, such as laser therapy, intense pulsed light (IPL), and topical agents, are offering targeted and effective solutions for pigment correction. Growing interest in minimally invasive and non-surgical procedures is further fueling adoption. Additionally, the influence of social media and beauty trends is encouraging individuals to seek professional treatment for skin tone improvement.

Expanding dermatology and cosmetic clinics worldwide is supporting broader access to pigmented lesion treatments. Research and development in novel formulations, including peptide-based creams and combination therapies, are enhancing treatment outcomes. Rising investments in skincare innovation and personalized treatment plans are creating new growth avenues. Increasing focus on sun protection and preventive care is also complementing the treatment market. With a growing emphasis on aesthetics, wellness, and self-care, the pigmented lesion treatment sector is poised for continued expansion and technological advancement.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/pigmented-lesion-treatment-market?sp

Pigmented Lesion Treatment Market: Major Players

Alma Lasers Ltd, Cutera Inc., Cynosure Inc., Lumenis Be Ltd., Lutronic Corporation, Lynton Lasers Ltd, Bausch Health, Fotona, Asclepion Laser Technologies, Candela Corporation among others.

Segment Covered in the Pigmented Lesion Treatment Market:

By Lesion Type
Pigmented lesion treatment targets conditions such as Freckles, Lentigines, Melasma, and Others. Melasma dominates the market due to its higher prevalence among women and growing demand for aesthetic treatments that offer effective pigmentation correction.

By Product Type
Products include Lasers and Energy-Based Devices, RF Devices, Ultrasound Devices, and Others. Lasers and energy-based devices lead the segment owing to their precision, minimal invasiveness, and effectiveness in removing or reducing pigmentation with faster recovery times.

By End User
End users comprise Dermatology Clinics, Hospitals, and Others. Dermatology clinics hold the largest share due to specialized expertise, availability of advanced aesthetic technologies, and the rising preference for outpatient cosmetic procedures.

Research Process:

Both primary and secondary data sources have been used in the Pigmented Lesion Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Pigmented Lesion Treatment Market Research Industry:

➠ Who leads the Pigmented Lesion Treatment industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Pigmented Lesion Treatment market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Pigmented Lesion Treatment market growth?
➠ What are the dominant sales and distribution strategies in the Pigmented Lesion Treatment industry?

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=pigmented-lesion-treatment-market
(Purchase 2 or more Repots and get 50% Discount)

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Pigmented Lesion Treatment Market expected to grow at a high CAGR during 2024-2031 | Top Companies - Alma Lasers Ltd, Cutera Inc., Cynosure Inc. here

News-ID: 4257457 • Views:

More Releases from DataM intelligence 4 Market Research LLP

United States Drug Discovery Services Market to Reach USD 12.78 Billion by 2033 | CAGR 4.9% | North America Leads with 44.98% Share | Key Players: Charles River Laboratories, Thermo Fisher Scientific, WuXi AppTec, Labcorp, Evotec
United States Drug Discovery Services Market to Reach USD 12.78 Billion by 2033 …
Drug Discovery Services Market Overview The global drug discovery services market reached US$ 8.37 Billion in 2024, up from US$ 8.01 Billion in 2023, and is projected to reach US$ 12.78 Billion by 2033, expanding at a CAGR of 4.9% during 2025-2033. The market's growth is primarily driven by the increasing prevalence of chronic diseases, rising pharmaceutical R&D expenditure, and advancements in drug discovery technologies. Pharmaceutical companies are increasingly outsourcing their
United States Biomaterials Market to Reach US$ 486.83 Million by 2033 | Rising Applications in Implants, Tissue Engineering, and Drug Delivery
United States Biomaterials Market to Reach US$ 486.83 Million by 2033 | Rising A …
Leander, Texas and TOKYO, Japan - Dec.10.2025 Market Size As per DataM Intelligence research report, "The Global Biomaterials Market reached US$ 177.30 million in 2024 and is expected to reach US$ 486.83 million by 2033, growing at a CAGR of 10.7% during the forecast period 2025-2033." Increasing applications in medical implants, tissue engineering, and drug delivery systems are driving market growth. Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/biomaterials-market?praveen United
United States Blood Cancer Drugs Market to Reach USD 113.5 Billion by 2031 | Strong 7.8% CAGR | North America Leads with 45% Share | Key Players: Amgen, AstraZeneca, Takeda, Bristol-Myers Squibb, Gilead Sciences
United States Blood Cancer Drugs Market to Reach USD 113.5 Billion by 2031 | Str …
Blood Cancer Drugs Market Overview The Global Blood Cancer Drugs Market reached USD 63 billion in 2022 and is projected to grow significantly to USD 113.5 billion by 2031, exhibiting a CAGR of 7.8% during 2024-2031. The market growth is primarily driven by the rising prevalence of blood cancers, continuous advancements in cancer research, and the development of targeted therapies, immunotherapies, and personalized medicine. Increasing awareness among patients and healthcare providers,
United States Primary Sclerosing Cholangitis Market 2031 | Growth Drivers, Key Players & Investment Opportunities
United States Primary Sclerosing Cholangitis Market 2031 | Growth Drivers, Key P …
Market Size and Growth The global critical infrastructure protection market is growing at a high CAGR during the forecast period (2024-2031). Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/primary-sclerosing-cholangitis-market?sb Key Development: United States ✅ In December 2025, Chemomab Therapeutics published peer‐reviewed Phase 2 trial results for Nebokitug showing that 48‐week treatment in PSC patients was generally safe, well tolerated and produced sustained improvements in biomarkers linked to

All 5 Releases


More Releases for Pigmented

Pigmented Villonodular Synovitis Drug Market Will Generate Record Revenue by 202 …
Pigmented villonodular synovitis drug market is anticipated to grow at a significant CAGR during the forecast period. Pigmented villonodular synovitis (PVNS) is a joint problem that affects the hip or knee and causes the lining of a joint to be swollen and grow which harms the bone around the joint. However, it can also occur in the shoulder, ankle, elbow, hand or foot. The major factor driving the growth of
Pigmented Lesion Treatment Market Top Players Revenue and Forecasts Research
"The Pigmented Lesion Treatment Market, Insights, Size, Growth, Challenges, Opportunities, Emerging Trends, and Geographic Regions, Forecast Period: to Pigmented Lesion Treatment Market" The emergence of new diseases, such as COVID-19 (novel coronavirus), is expected to propel the Pigmented Lesion Treatment Market growth during the forecast period. According to the World Health Organization (WHO), new diseases have been emerging at the unprecedented rate of one a year for the last two decades,
Pigmented Concrete Market - Forecast to 2026
As per the research conducted by GME, the Pigmented Concrete Market will grow with a CAGR value of around 7 percent over the forecast period. Browse TOC on “Global Pigmented Concrete Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-pigmented-concrete-market-2739 By Type (Stained, Dyed, Paint, Tinted Sealers, Integral Colour, Dry Shake Colour Hardener), By Application (Walls, Floors, Driveways & Sidewalks, Pool Decks, Patios), By End-Use (Residential, Non-Residential), By Region (North America, Asia Pacific, Europe,
Global Pigmented Paper Market Outlook (2014-2025)
The report on the global Pigmented Paper market has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Pigmented Paper market. Players can use the accurate market facts and figures and statistical studies provided in the report to understand the current and future growth of the
Pigmented Paper Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Pigmented Paper Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Pigmented Paper players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Pigmented Paper with respect to individual growth
Pigmented Lesion Treatment Market – Worldwide Transformation Overview 2025 | L …
Global Pigmented Lesion Treatment Market: Overview The global market for pigmented lesion treatment is poised for a steady growth in the years ahead. Increasing prevalence of pigmented lesions is serving to drive the demand for its treatment worldwide. Pigmented lesions is a common skin condition among the geriatric population. Mostly visible on the face, it can be visible on other parts of the body as well. Extreme exposure to sun and aging